patent-invalidity
9 cases — ← All topics
| Case | Title | Lower Court | Docketed | Status | Flags | Tags | Question Presented |
|---|---|---|---|---|---|---|---|
| 22-803 | Virentem Ventures, LLC v. Google LLC | Federal Circuit | 2023-02-24 | Denied | Response Waived | claim-construction due-process federal-circuit patent patent-invalidity ptab ptab-determination rule-36 | 1. Does the Federal Circuit's use of Rule 36 to affirm without opinion PTAB invalidity determinations that are challenged based on pure questions of l… |
| 22-544 | Innovation Sciences, LLC v. Amazon.com, Inc., et al. | Federal Circuit | 2022-12-14 | Denied | Response Waived | 35-usc-102 anticipation anticipatory-reference clear-and-convincing clear-and-convincing-evidence invention patent patent-infringement patent-invalidity prior-art | In Washburn & Moen Mfg. Co. v. Beat 'Em All Barbed-Wire Co., 143 U.S. 275 (1892) (also known as "Barbed Wire Patent"), the Court found the burden to e… |
| 21-1458 | EPA Drug Initiative II v. Hikma Pharmaceuticals USA Inc., et al. | Federal Circuit | 2022-05-18 | Denied | Response Waived | appellate-review fraud-on-court fraud-on-the-court hazel-atlas-doctrine hazel-atlas-glass-co-v-hartford-empire-co judicial-proceedings patent-invalidation patent-invalidity standing supervisory-power third-party-intervention | Under this Court's Rule 10(a), certiorari can be granted where a United States court of appeals has so far departed from the accepted and usual course… |
| 20-440 | Minerva Surgical, Inc. v. Hologic, Inc., et al. | Federal Circuit | 2020-10-06 | Judgment Issued | Amici (12)Relisted (2) | 35-usc-282 assignor-estoppel due-process judicial-doctrine patent patent-infringement patent-invalidity patent-law statutory-interpretation | In the Patent Act, Congress established that invalidity is a "defense[] in any action involving the validity or infringement of a patent." 35 U.S.C. §… |
| 19-101 | Imperium IP Holdings (Cayman), Ltd. v. Samsung Electronics Co., Ltd., et al. | Federal Circuit | 2019-07-19 | Denied | Amici (2)Response Waived | appellate-review burden-of-proof credibility-determinations credibility-of-witnesses expert-testimony jury-trial jury-trial-rights jury-verdict patent-infringement patent-invalidity patent-validity seventh-amendment standard-of-review | The question presented is whether an appellate court may reverse a jury verdict based on its own view that expert testimony was credible, "unrebutted,… |
| 18-1397 | Prism Technologies LLC v. Sprint Spectrum L.P., dba Sprint PCS | Federal Circuit | 2019-05-06 | Denied | Response Waived | 35-usc-101 appellate-jurisdiction collateral-estoppel federal-circuit federal-circuit-jurisdiction jurisdiction-scope mandate-rule patent-claims patent-eligibility patent-invalidity retroactive-expansion | Whether the Federal Circuit Court of Appeals may retroactively expand the scope of its appellate jurisdiction to invalidate patent claims under 35 U.S… |
| 18-823 | ZUP, LLC v. Nash Manufacturing, Inc. | Federal Circuit | 2018-12-28 | Denied | Amici (1)Response Waived | invention invention-evaluation legal-analysis long-felt-need non-obviousness obviousness obviousness-standard patent patent-invalidity patent-law prima-facie prior-art rebuttal secondary-considerations | Whether evidence of "secondary considerations" (e.g., a long-felt, but unresolved, need for the patented invention) is less important, functioning at … |
| 18-190 | Queen's University at Kingston v. Samsung Electronics Co., Ltd., et al. | Federal Circuit | 2018-08-13 | Denied | Response Waived | administrative-procedure-act burden-of-proof due-process enablement inter-partes-review patent-invalidity prior-art | Does the Federal Circuit's requirement that patent owners negate enablement of prior art in the first instance invert the statutory burden of proving … |
| 18-182 | AIDS Healthcare Foundation, Inc. v. Gilead Sciences, Inc., et al. | Federal Circuit | 2018-08-09 | Denied | Response Waived | actual-controversy article-iii declaratory-judgment drug-exclusivity fda-approval generic-drugs patent-invalidity pharmaceutical pharmaceutical-patents standing | In the context of patent cases involving pharmaceutical products, does the "actual controversy" requirement of the Declaratory Judgment Act, 28 U.S.C.… |